Inventor
KINDSVOGEL WAYNE R
US63 patents
⚠️ This page may combine multiple inventors who share the name “KINDSVOGEL WAYNE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ZYMOGENETICS INC
20 patentsUS7351689B2Apr 1, 2008
Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
ZYMOGENETICS INC68 citations98
US6323323B1Nov 27, 2001
Ligand-binding, dimerized polypeptide fusions
ZYMOGENETICS INC196 citations98
US6300099B1Oct 9, 2001
Methods for producing secreted ligand-binding fusion proteins
ZYMOGENETICS INC129 citations98
US6291212B1Sep 18, 2001
DNA constructs encoding ligand-binding fusion proteins
ZYMOGENETICS INC134 citations98
US6291646B1Sep 18, 2001
Dimerized polypeptide fusions
ZYMOGENETICS INC146 citations98
US6018026AJan 25, 2000
Biologically active dimerized and multimerized polypeptide fusions
ZYMOGENETICS INC148 citations98
US5843725ADec 1, 1998
Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
ZYMOGENETICS INC179 citations98
US5750375AMay 12, 1998
Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
ZYMOGENETICS INC95 citations97
US5567584AOct 22, 1996
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
ZYMOGENETICS INC122 citations97
US5155027AOct 13, 1992
Method of producing secreted receptor analogs and biologically active peptide dimers
ZYMOGENETICS INC211 citations97
US7135170B2Nov 14, 2006
Methods for treating viral infection using IL-28 and IL-29
ZYMOGENETICS INC97 citations96
US5770445AJun 23, 1998
Glucagon receptor proteins, peptides, and antibodies
ZYMOGENETICS INC47 citations96
US7537761B2May 26, 2009
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC18 citations92
US7393684B2Jul 1, 2008
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
ZYMOGENETICS INC25 citations92
US5919635AJul 6, 1999
Method of detecting glucagon receptor antagonists
ZYMOGENETICS INC20 citations92
US5776725AJul 7, 1998
Recombinant production of glucagon receptors
ZYMOGENETICS INC41 citations92
US7045498B2May 16, 2006
Soluble Zcytor11 cytokine receptors
ZYMOGENETICS INC14 citations83
US4985541AJan 15, 1991
Novel cytotoxic protein
ZYMOGENETICS INC8 citations74
US5149528ASep 22, 1992
Cytotoxic protein from Trichosanthes kirilowii
ZYMOGENETICS INC6 citations63
US7871616B2Jan 18, 2011
Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
ZYMOGENETICS INC1 citations62
ELWHA LLC
13 patentsUS9499855B2Nov 22, 2016
Compositions, methods, and computer systems related to making and administering modified T cells
ELWHA LLC108 citations98
US9587237B2Mar 7, 2017
Compositions, methods, and computer systems related to making and administering modified T cells
ELWHA LLC15 citations84
US10667742B2Jun 2, 2020
Systems, devices and methods for monitoring breastfeeding
ELWHA LLC3 citations73
US10233424B2Mar 19, 2019
Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin
ELWHA LLC2 citations73
US9707116B2Jul 18, 2017
Gastrointestinal device with associated microbe-promoting agents
ELWHA LLC2 citations73
US9662354B2May 30, 2017
Compositions, methods, and computer systems related to making and administering modified T cells
ELWHA LLC5 citations73
US9649185B2May 16, 2017
Adjuncts for gastrointestinal devices
ELWHA LLC4 citations73
US10772507B2Sep 15, 2020
Systems, devices and methods for monitoring breastfeeding
ELWHA LLC1 citations63
US9901598B2Feb 27, 2018
Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
ELWHA LLC1 citations63
US9512213B2Dec 6, 2016
Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
ELWHA LLC2 citations63
US9956106B2May 1, 2018
Gastrointestinal device with associated commensal microbes
ELWHA LLC0 citations52
US9949855B2Apr 24, 2018
Gastrointestinal device with associated microbe-promoting agents
ELWHA LLC0 citations52
US9845351B2Dec 19, 2017
Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
ELWHA LLC0 citations52
HYDE RODERICK A
8 patentsUS9175072B2Nov 3, 2015
Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
HYDE RODERICK A7 citations84
US8154285B1Apr 10, 2012
Non-external static magnetic field imaging systems, devices, methods, and compositions
HYDE RODERICK A7 citations84
US8106655B2Jan 31, 2012
Multiplex imaging systems, devices, methods, and compositions including ferromagnetic structures
HYDE RODERICK A9 citations84
US8063636B2Nov 22, 2011
Systems, devices, methods, and compositions including targeted ferromagnetic structures
HYDE RODERICK A9 citations84
US9286615B2Mar 15, 2016
Devices and methods for recording information on a subject's body
HYDE RODERICK A4 citations73
US9443061B2Sep 13, 2016
Devices and methods for recording information on a subject's body
HYDE RODERICK A2 citations63
US8962315B2Feb 24, 2015
Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
HYDE RODERICK A1 citations63
US8058872B2Nov 15, 2011
Systems, devices, methods, and compositions including functionalized ferromagnetic structures
HYDE RODERICK A5 citations63
KOTA BIOTHERAPEUTICS LLC
3 patentsUS10745468B2Aug 18, 2020
Compositions and methods for modified B cells expressing reassigned biological agents
KOTA BIOTHERAPEUTICS LLC3 citations71
US10597442B2Mar 24, 2020
Compositions and methods for modified B cells expressing reassigned biological agents
KOTA BIOTHERAPEUTICS LLC2 citations71
US11993646B2May 28, 2024
Compositions and methods for modified b cells expressing reassigned biological agents
KOTA BIOTHERAPEUTICS LLC0 citations61
KLUCHER KEVIN M
2 patentsXU WENFENG
2 patentsZYMOGENETICS LLC
1 patentTHE INVENT SCIENCE FUND II LLC
1 patentShowing the top 50 of 63 patents by PatentIndex Score.